ArticleAging2021

Inhibition of FSTL3 abates the proliferation and metastasis of renal cell carcinoma via the GSK-3β/β-catenin signaling pathway.

Fengfeng Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.